Maja Sedic

1.2k total citations
16 papers, 740 citations indexed

About

Maja Sedic is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Maja Sedic has authored 16 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Genetics. Recurrent topics in Maja Sedic's work include CAR-T cell therapy research (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Cells and Metastasis (3 papers). Maja Sedic is often cited by papers focused on CAR-T cell therapy research (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer Cells and Metastasis (3 papers). Maja Sedic collaborates with scholars based in United States, Spain and Türkiye. Maja Sedic's co-authors include Charlotte Kuperwasser, Theresa A. Proia, Patricia J. Keller, Piyush B. Gupta, Stephen P. Naber, Eric S. Lander, Ina Klebba, Hannah Gilmore, Stuart J. Schnitt and Nadine Tung and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Maja Sedic

14 papers receiving 723 citations

Peers

Countries citing papers authored by Maja Sedic

Since Specialization

Citations

This map shows the geographic impact of Maja Sedic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Sedic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Sedic more than expected).

Fields of papers citing papers by Maja Sedic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maja Sedic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Sedic. The network helps show where Maja Sedic may publish in the future.

Co-authorship network of co-authors of Maja Sedic

This figure shows the co-authorship network connecting the top 25 collaborators of Maja Sedic. A scholar is included among the top collaborators of Maja Sedic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maja Sedic. Maja Sedic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	In Vivo pan CAR therapy utilizing circular RNA for treatment of autoimmune diseases 2025 ·Blood ·David Soto, Juliet Crabtree, Thomas Lee, (unknown), (unknown), Akinola Olumide Emmanuel, Matthew Theisen, (unknown), Maja Sedic, (unknown), Muthusamy Jayaraman, Megan D. Hoban, Frank Neumann, Joe Bolen, (unknown)	0
2	In Vivo pan CAR therapy utilizing circular RNA for treatment of multiple myeloma 2025 ·Blood ·Rebecca Silver, Jeffrey W. Schindler, (unknown), (unknown), Changqing Sun, (unknown), (unknown), Dong Wei, (unknown), Rajat Das, Muthusamy Jayaraman, Maja Sedic, Megan D. Hoban, Frank Neumann, Joe Bolen, (unknown)	0
3	In Vivo panCAR-Mediated Depletion of B Cells in Non-Human Primates Using a Circular (oRNA®) Anti-CD20 CAR 2024 ·Blood ·Juliet Crabtree, Akinola Olumide Emmanuel, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David Soto, (unknown), Grace Chen, Maja Sedic, Scott Barros, Allen Horhota, (unknown), (unknown), Muthusamy Jayaraman, Megan D. Hoban, Frank Neumann, (unknown)	2
4	The Simultaneous Inhibition of Solute Carrier Family 6 Member 19 and Breast Cancer Resistance Protein Transporters Leads to an Increase of Indoxyl Sulfate (a Uremic Toxin) in Plasma and Kidney 2024 ·Drug Metabolism and Disposition ·(unknown), Bogdan Munteanu, (unknown), (unknown), (unknown), (unknown), Theresa A. Kuntzweiler, (unknown), Maja Sedic, Zaid Jayyosi, (unknown), Jennifer Fretland	1
5	Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis against Enterotoxigenic Escherichia coli Infection 2018 ·Infection and Immunity ·Serena Giuntini, Matteo Stoppato, Maja Sedic, Monir Ejemel, (unknown), (unknown), Zachary A. Schiller, William D. Thomas, Eileen M. Barry, Lisa A. Cavacini, Mark S. Klempner, Yang Wang	19
6	Abstract 1607: Durable efficacy and anti-cancer immunity following intratumoral administration of messenger RNAs encoding IL-36γ, IL-23 and OX40L 2017 ·Cancer Research ·(unknown), Ailin Bai, Susannah L. Hewitt, (unknown), John Zielinski, Kana Ichikawa, Ameya Apte, D. R. Shackleton Bailey, Kristen Arnold, (unknown), (unknown), Bo Ying, (unknown), Kerry E. Benenato, Maja Sedic, (unknown)	1
7	Epigenetic Reprogramming of Lineage-Committed Human Mammary Epithelial Cells Requires DNMT3A and Loss of DOT1L 2017 ·Stem Cell Reports ·Jerrica L. Breindel, Adam Skibinski, Maja Sedic, (unknown), Wenhui Zhou, Patricia J. Keller, Joslyn Mills, James E. Bradner, Tamer T. Önder, Charlotte Kuperwasser	14
8	Safety Evaluation of Lipid Nanoparticle–Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey 2017 ·Veterinary Pathology ·Maja Sedic, Joseph J. Senn, (unknown), Michael E. Laska, Mike Smith, Stefan Platz, Joseph B. Bolen, Stephen Hoge, Alex Bulychev, Eric Jacquinet, Victoria J. Bartlett, Peter F. Smith	148
9	BRCA1-hapoinsufficiency: Unraveling the molecular and cellular basis for tissue-specific cancer 2016 ·Cell Cycle ·Maja Sedic, Charlotte Kuperwasser	17
10	Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence 2015 ·Nature Communications ·Maja Sedic, Adam Skibinski, Nelson E. Brown, Mercedes Gallardo, Peter Mulligan, Paula Martínez, Patricia J. Keller, (unknown), Andrea L. Richardson, Janet M. Cowan, Amanda E. Toland, Krithika Ravichandran, Harold Riethman, Stephen P. Naber, Anders M. Näär, Marı́a A. Blasco, Philip W. Hinds, Charlotte Kuperwasser	94
11	CoREST1 Promotes Tumor Formation and Tumor Stroma Interactions in a Mouse Model of Breast Cancer 2015 ·PLoS ONE ·(unknown), Lisa M. Arendt, Sarah Phillips, Maja Sedic, Charlotte Kuperwasser, Grace Gill	9
12	Cell-State Transitions Regulated by SLUG Are Critical for Tissue Regeneration and Tumor Initiation 2014 ·Stem Cell Reports ·Sarah Phillips, Aleix Prat, Maja Sedic, Theresa A. Proia, Ania Wronski, (unknown), Adam Skibinski, Stephanie H. Shirley, Charles M. Perou, Grace Gill, Piyush B. Gupta, Charlotte Kuperwasser	81
13	Resolving self-association of a therapeutic antibody by formulation optimization and molecular approaches 2014 ·mAbs ·Paul Casaz, (unknown), (unknown), Brian G. Pierce, (unknown), Maja Sedic, Sadettin S. Ozturk, William D. Thomas, Yang Wang	21
14	Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate 2011 ·Cell stem cell ·Theresa A. Proia, Patricia J. Keller, Piyush B. Gupta, Ina Klebba, (unknown), Maja Sedic, Hannah Gilmore, Nadine Tung, Stephen P. Naber, Stuart J. Schnitt, Eric S. Lander, Charlotte Kuperwasser	284
15	Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate 2011 ·DSpace@MIT (Massachusetts Institute of Technology) ·Theresa A. Proia, Patricia J. Keller, Ina Klebba, (unknown), Maja Sedic, Hannah Gilmore, Nadine Tung, Stephen P. Naber, Stuart J. Schnitt, (unknown), Eric S. Lander, Charlotte Kuperwasser	10
16	Membrane Morphology and Leukotoxin Secretion Are Associated with a Novel Membrane Protein ofAggregatibacter actinomycetemcomitans 2008 ·Journal of Bacteriology ·(unknown), Maja Sedic, (unknown), Teresa Ruíz, Keith P. Mintz	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact